Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials
- PMID: 29966732
- PMCID: PMC6175611
- DOI: 10.1016/j.jclinepi.2018.06.009
Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials
Abstract
Objectives: Pragmatic randomized trials are important tools for shared decision-making, but no guidance exists on patients' preferences for types of causal information. We aimed to assess preferences of patients and investigators toward causal effects in pragmatic randomized trials.
Study design and setting: We (a) held three focus groups with patients (n = 23) in Boston, MA; (b) surveyed (n = 12) and interviewed (n = 5) investigators with experience conducting pragmatic trials; and (c) conducted a systematic literature review of pragmatic trials (n = 63).
Results: Patients were distrustful of new-to-market medications unless substantially more effective than existing choices, preferred stratified absolute risks, and valued adherence-adjusted analyses when they expected to adhere. Investigators wanted both intention-to-treat and per-protocol effects but felt methods for estimating per-protocol effects were lacking. When estimating per-protocol effects, many pragmatic trials used inappropriate methods to adjust for adherence and loss to follow-up.
Conclusion: We made four recommendations for pragmatic trials to improve patient centeredness: (1) focus on superiority in effectiveness or safety, rather than noninferiority; (2) involve patients in specifying a priori subgroups; (3) report absolute measures of risk; and (4) complement intention-to-treat effect estimates with valid per-protocol effect estimates.
Keywords: Adherence adjustment; Causal inference; Health communication; Intention to treat; Patient preferences; Per protocol; Pragmatic trial.
Copyright © 2018 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.BMC Med Ethics. 2018 Nov 20;19(1):90. doi: 10.1186/s12910-018-0332-z. BMC Med Ethics. 2018. PMID: 30458809 Free PMC article.
-
Intention to treat and per protocol analyses: differences and similarities.J Clin Epidemiol. 2024 Sep;173:111457. doi: 10.1016/j.jclinepi.2024.111457. Epub 2024 Jul 6. J Clin Epidemiol. 2024. PMID: 38977160 Review.
-
Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.Trials. 2016 Aug 22;17(1):419. doi: 10.1186/s13063-016-1546-3. Trials. 2016. PMID: 27550379 Free PMC article.
-
Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.Trials. 2017 Nov 10;18(1):532. doi: 10.1186/s13063-017-2267-y. Trials. 2017. PMID: 29126437 Free PMC article.
-
Pragmatic study designs for older adults with cancer: Report from the U13 conference.J Geriatr Oncol. 2016 Jul;7(4):234-41. doi: 10.1016/j.jgo.2016.02.005. Epub 2016 Jul 5. J Geriatr Oncol. 2016. PMID: 27197914 Review.
Cited by
-
Early introduction of peanut reduces peanut allergy across risk groups in pooled and causal inference analyses.Allergy. 2023 May;78(5):1307-1318. doi: 10.1111/all.15597. Epub 2022 Dec 11. Allergy. 2023. PMID: 36435990 Free PMC article. Clinical Trial.
-
A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.J Clin Epidemiol. 2021 Sep;137:45-57. doi: 10.1016/j.jclinepi.2021.03.021. Epub 2021 Mar 28. J Clin Epidemiol. 2021. PMID: 33789151 Free PMC article. Review.
-
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients.Addiction. 2024 Nov;119(11):1975-1986. doi: 10.1111/add.16630. Epub 2024 Aug 5. Addiction. 2024. PMID: 39099417
-
A randomized trial of web-based fertility-tracking software and fecundability.Fertil Steril. 2023 Jun;119(6):1045-1056. doi: 10.1016/j.fertnstert.2023.02.005. Epub 2023 Feb 10. Fertil Steril. 2023. PMID: 36774978 Free PMC article. Clinical Trial.
-
Smoking cessation and survival among people diagnosed with non-metastatic cancer.BMC Cancer. 2020 Aug 5;20(1):726. doi: 10.1186/s12885-020-07213-5. BMC Cancer. 2020. PMID: 32758159 Free PMC article.
References
-
- Härter M, Simon D. Shared decision-making in diverse health care systems—Translating research into practice. Patient Education and Counseling. 2008;73(3):399–401. - PubMed
-
- Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ. Systematic Review of the Effects of Shared Decision-Making on Patient Satisfaction, Treatment Adherence and Health Status. Psychotherapy and psychosomatics. 2008;77(4):219–26. - PubMed
-
- Zipkin DA, Umscheid CA, Keating NL, Allen E, Aung K, Beyth R, et al. Evidence-based risk communication: a systematic review. Ann Intern Med. 2014;161(4):270–80. - PubMed
-
- Epstein AM, Taylor WC, Seage GR., 3rd Effects of patients’ socioeconomic status and physicians’ training and practice on patient-doctor communication. Am J Med. 1985;78(1):101–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical